Ireland· IE-PA-EU/1/21/1577/001
Voxzogo 0.4 mg powder and solvent for solution for injection
A vosoritide product containing vosoritide, registered in Ireland by Biomarin International Limited. The same ATC class is registered in 10 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Vosoritide is registered in 10 of 19 countries.
Countries holding a registration under ATC M05BX07 (vosoritide), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Vosoritide · ATC M05BX07
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Vosoritide
- Manufacturer
- Biomarin International Limited
- Country
- Ireland (IE)
- ATC code
- M05BX07
- ATC class
- Vosoritide
- Defined daily dose
- 0.4 mg, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/21/1577/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vosoritide in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceVOXZOGO 0,4 mg, poudre et solvant pour solution injectableBIOMARIN INTERNATIONAL LIMITED (IRLANDE)
- NetherlandsVoxzogo 0,4 mg, poeder en oplosmiddel voor oplossing voor injectieBioMarin International Limited
- SwitzerlandVoxzogo 0.4 mg, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungDRAC AG
- CzechiaVOXZOGOBioMarin International Limited, Dublin
- SpainVOXZOGO 0,4 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLEBiomarin International Limited
- FinlandVoxzogoBiomarin International Limited
- IcelandVoxzogoBioMarin International Limited
- Japanボソリチド（遺伝子組換え）ＢｉｏＭａｒｉｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｊａｐａｎ
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Voxzogo
- Liechtenstein · Voxzogo
- Norway · Voxzogo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/faf3c147-6bbd-4cc0-9a7a-e02e1764c764 GET /v1/drugs/faf3c147-6bbd-4cc0-9a7a-e02e1764c764?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for injection",
"routes": [
"Subcutaneous use"
],
"source": "hpra",
"atc_all": [
"M05BX",
"M05BX07"
],
"strength": null,
"pa_number": "EU/1/21/1577/001",
"substances": [
"Vosoritide"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "26/08/2021",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about vosoritide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.